| Esther Tompkins, DO | |
|
1 Childrens Way # 653, Little Rock, AR 72202-3500 | |
| (501) 364-1100 | |
| (501) 364-4082 |
| Full Name | Esther Tompkins |
|---|---|
| Gender | Female |
| Speciality | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine |
| Location | 1 Childrens Way # 653, Little Rock, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114017613 | NPI | - | NPPES |
| 141440003 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P0010X | Physical Medicine & Rehabilitation - Pediatric Rehabilitation Medicine | E-2673 (Arkansas) | Primary |
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706 |
News Archive
CANCER RESEARCH UK scientists have shown for the first time how a natural 'defence' gene involved in fighting infections such as common colds, can be triggered by hormones to ignite and drive cancers like breast, ovarian, and possibly prostate cancer. Their findings are published in the Journal of Experimental Medicine.
High school students participating in school meal programs are less likely to select milk, whole fruit, and water when fruit juice is available, which on balance may decrease the nutritional quality of their lunches, according to a new study by the Rudd Center for Food Policy and Obesity at the University of Connecticut.
Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.
A blood sample could one day be enough to diagnose many types of solid cancers, or to monitor the amount of cancer in a patient's body and responses to treatment. Previous versions of the approach, which relies on monitoring levels of tumor DNA circulating in the blood, have required cumbersome and time-consuming steps to customize it to each patient or have not been sufficiently sensitive.
› Verified 5 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346230968 PECOS PAC ID: 4082528955 Enrollment ID: O20040115000431 |
News Archive
CANCER RESEARCH UK scientists have shown for the first time how a natural 'defence' gene involved in fighting infections such as common colds, can be triggered by hormones to ignite and drive cancers like breast, ovarian, and possibly prostate cancer. Their findings are published in the Journal of Experimental Medicine.
High school students participating in school meal programs are less likely to select milk, whole fruit, and water when fruit juice is available, which on balance may decrease the nutritional quality of their lunches, according to a new study by the Rudd Center for Food Policy and Obesity at the University of Connecticut.
Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.
A blood sample could one day be enough to diagnose many types of solid cancers, or to monitor the amount of cancer in a patient's body and responses to treatment. Previous versions of the approach, which relies on monitoring levels of tumor DNA circulating in the blood, have required cumbersome and time-consuming steps to customize it to each patient or have not been sufficiently sensitive.
› Verified 5 days ago
| Entity Name | Arkansas Childrens Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598773079 PECOS PAC ID: 2769477744 Enrollment ID: O20040419000796 |
News Archive
CANCER RESEARCH UK scientists have shown for the first time how a natural 'defence' gene involved in fighting infections such as common colds, can be triggered by hormones to ignite and drive cancers like breast, ovarian, and possibly prostate cancer. Their findings are published in the Journal of Experimental Medicine.
High school students participating in school meal programs are less likely to select milk, whole fruit, and water when fruit juice is available, which on balance may decrease the nutritional quality of their lunches, according to a new study by the Rudd Center for Food Policy and Obesity at the University of Connecticut.
Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.
A blood sample could one day be enough to diagnose many types of solid cancers, or to monitor the amount of cancer in a patient's body and responses to treatment. Previous versions of the approach, which relies on monitoring levels of tumor DNA circulating in the blood, have required cumbersome and time-consuming steps to customize it to each patient or have not been sufficiently sensitive.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Esther Tompkins, DO 1 Childrens Way # 653, Little Rock, AR 72202-3500 Ph: (501) 364-1100 | Esther Tompkins, DO 1 Childrens Way # 653, Little Rock, AR 72202-3500 Ph: (501) 364-1100 |
News Archive
CANCER RESEARCH UK scientists have shown for the first time how a natural 'defence' gene involved in fighting infections such as common colds, can be triggered by hormones to ignite and drive cancers like breast, ovarian, and possibly prostate cancer. Their findings are published in the Journal of Experimental Medicine.
High school students participating in school meal programs are less likely to select milk, whole fruit, and water when fruit juice is available, which on balance may decrease the nutritional quality of their lunches, according to a new study by the Rudd Center for Food Policy and Obesity at the University of Connecticut.
Oxygen Biotherapeutics, Inc. reported today that the Data Safety Monitoring Board overseeing the company's ongoing Phase II-b trial has, based on the results of the first cohort of patients, authorized the company to move forward with the next cohort of the study. This trial is a randomized, single-dose, placebo-controlled, double-blind, dose-escalation study to evaluate the safety and tolerability of our Oxycyte® emulsion in patients with severe non-penetrating traumatic brain injury.
A blood sample could one day be enough to diagnose many types of solid cancers, or to monitor the amount of cancer in a patient's body and responses to treatment. Previous versions of the approach, which relies on monitoring levels of tumor DNA circulating in the blood, have required cumbersome and time-consuming steps to customize it to each patient or have not been sufficiently sensitive.
› Verified 5 days ago
Mike C Umerah, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 500 S University Ave, Suite 705, Little Rock, AR 72205 Phone: 501-664-2991 Fax: 501-664-7111 | |
Dr. Regina Kay Pondexter Hunter, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 500 S University Ave Ste 318, Little Rock, AR 72205 Phone: 501-225-6900 Fax: 501-225-6911 | |
Dr. David C Culver, DO Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4300 W 7th St, Little Rock, AR 72205 Phone: 501-257-1000 Fax: 501-257-6419 | |
Stephen Paulus, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 800 Fair Park Blvd, Little Rock, AR 72204 Phone: 501-604-6900 Fax: 501-604-6941 | |
Dr. Leigh Henderson, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 9501 Baptist Health Dr Fl 1, Little Rock, AR 72205 Phone: 501-202-7395 Fax: 501-202-7333 | |
Mark Reed, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 |